Wordt geladen...
Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models
BACKGROUND: DNA vaccines represent an attractive approach for cancer treatment by inducing active T cell and B cell immune responses to tumor antigens. Previous studies have shown that interleukin-13 receptor α2 chain (IL-13Rα2), a tumor-associated antigen is a promising target for cancer immunother...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2993653/ https://ncbi.nlm.nih.gov/pubmed/21067607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-8-116 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|